The relationship between circulating fibrinogen and lipoprotein (a) levels in patients with primary dyslipidemia

被引:10
|
作者
Ganotakis, Emmanuel S.
Gazi, Irene F.
Papadakis, John A.
Jagroop, I. Anita
Nair, Devaki R.
Mikhailidis, Dimitri P.
机构
[1] Royal Free & Vet Coll Med Sch, Dept Clin Biochem, Vasc Dis Prevent Clin, London NW3 2QG, England
[2] Royal Free Hosp, Hampstead NHS Trust, Dept Clin Biochem, Vasc Dis Prevent Clin, London NW3 2QG, England
[3] Univ Crete, Univ Hosp Heraklion, Sch Med, Dept Internal Med, Iraklion, Crete, Greece
关键词
cardiovascular risk; dyslipidemia; fibrinogen; lipoprotein (a); smoking;
D O I
10.1177/1076029606296256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The correlation between 2 predictors of vascular events, plasma fibrinogen and serum lipoprotein (a), was evaluated in patients referred to a specialist clinic because of primary hyperlipidemia. A significant correlation existed between fibrinogen and lipoprotein (a) in nonsmokers but not in smokers. Plasma fibrinogen concentration correlated positively and significantly with serum lipoprotein (a) levels in men nonsmokers without cardiovascular disease and in women nonsmokers with cardiovascular disease. Nonsmoker women without cardiovascular disease had significantly higher plasma fibrinogen (3.63 g/L versus 3.07 g/L, P <.0001) than the corresponding men. Nonsmoker women with and without cardiovascular disease had significantly higher lipoprotein (a) levels than the corresponding groups of men (0.36 versus 0.18 g/L; P=.0015 and 0.40 versus 0.26 g/L; P=.008), respectively The relationship between fibrinogen and lipoprotein (a) levels alters markedly depending on the population selected. This relationship is influenced by gender, the presence of cardiovascular disease and smoking status.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [1] Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia
    Papadakis, JA
    Ganotakis, ES
    Jagroop, IA
    Mikhailidis, DP
    Winder, AF
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (07) : 673 - 681
  • [2] EFFECTS OF NICERITROL ON LEVELS OF SERUM-LIPIDS, LIPOPROTEIN(A), AND FIBRINOGEN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
    MATSUNAGA, A
    HANDA, K
    MORI, T
    MORIYAMA, K
    HIDAKA, K
    YUKI, M
    SASAKI, J
    ARAKAWA, K
    ATHEROSCLEROSIS, 1992, 94 (2-3) : 241 - 248
  • [3] Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men
    Bremner, WF
    Sothern, RB
    Kanabrocki, EL
    Ryan, M
    McCormick, JB
    Dawson, S
    Connors, ES
    Rothschild, R
    Third, JLHC
    Vahed, S
    Nemchausky, BM
    Shirazi, P
    Olwin, JH
    AMERICAN HEART JOURNAL, 2000, 139 (01) : 164 - 173
  • [4] Relationship between levels suPAR circulating and biomarkers of endothelial dysfunction in patients with primary nephrotic syndrome
    Roca, N.
    Jatem, E.
    Martin, M.
    Munoz, M.
    Pmarco, M.
    Molina, M.
    Segarra, A.
    deVic, H.
    de Vilanova, H. U. Arnau
    PEDIATRIC NEPHROLOGY, 2019, 34 (05) : 744 - 744
  • [5] Relationship between lipoprotein(a), fibrinogen, and fibronectin in non-diabetic hemodialyzed uremic patients
    Tzanatos, HA
    Retsa, K
    Soubassi, L
    Rizos, D
    Skiadas, M
    Bougatsos, G
    Agroyannis, B
    DIALYSIS & TRANSPLANTATION, 2006, 35 (03) : 136 - +
  • [6] Relationship between thyroid hormones and fibrinogen levels
    Chadarevian, R
    Bruckert, E
    Giral, P
    Turpin, G
    BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (08) : 481 - 486
  • [7] THE RELATIONSHIP BETWEEN LIPOPROTEIN (A), MITRAL ANNULAR CALCIFICATION, AND MITRAL STENOSIS IN A LARGE COHORT OF DYSLIPIDEMIA PATIENTS
    Shah, Nishant
    Riaz, Hans
    Kaul, Risheek
    Kanishka, Antonette
    Cho, Leslie
    Ahmed, Haitham
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1778 - 1778
  • [8] Effect of ezetimibe monotherapy on lipidemic profile, fibrinogen and C-reactive protein levels in patients with primary dyslipidemia
    Paschalidou, H.
    Efthimiadis, A.
    Tavridou, A.
    Efthimiadis, I.
    Dogramatzi, F.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 558 - 558
  • [9] The relationship between circulating irisin levels and endothelial function in obese patients
    Sun, X.
    Hou, N.
    Han, F.
    Huang, N.
    Zhao, J.
    Liu, X.
    DIABETOLOGIA, 2014, 57 : S526 - S526
  • [10] Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome
    Stancakova, A.
    Baldaufova, L.
    Javorsky, M.
    Kozarova, M.
    Salagovic, J.
    Tkac, I.
    PHYSIOLOGICAL RESEARCH, 2006, 55 (05) : 483 - 490